This study demonstrated that the neuregulin-1 and P2Y purinergic G-protein coupled receptor proteins mediate resistance to the ALK inhibitors, TAE684 and crizotinib, in lung cancer [31]. The gene discussed is ALK; the disease is lung carcinoma.